Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia

NCT00407277 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.

NCT NCT00407277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia
Lead sponsor
Centre for Addiction and Mental Health
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2007
Completion date
Not reported
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence, psychosis, schizoaffective disorder, schizophrenia, schizophreniform disorders, smoking